… company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer® RNAediting technology platform, today announced that Daniel …
… company dedicated to changing lives through transformative RNA therapies today provided an update that its previously … our primary focus at ProQR remains on our Axiomer ® RNAediting platform,” said Daniel A. de Boer, Founder and …
… opinion leaders and introduced next-generation Axiomer ® RNA technology platform. LEIDEN, the Netherlands, Aug. 16, … In May, three abstracts were presented on three of ProQR’s RNAediting approaches for inherited blindness at the Annual …